Biohaven Pharmaceuticals, INC.
A biopharmaceutical company.
Based in CT
🤖
AI Overview
With $730K in lobbying spend across 15 quarterly filings, Biohaven Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
$730K
Total Spend
4
Years Active
1
Firms Hired
5
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $20K |
| 2023 | $230K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Policies, proposals, and FDA regulation of pharmaceuticals in disease areas served by Biohaven.
- •Policies related to drug approval for treatment of rare diseases. Policies related to exclusivity of small molecule drugs.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.